Works matching AU Loriot, Yohann

Results: 54
    1

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    2

    Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.

    Published in:
    JNCI Cancer Spectrum, 2024, v. 8, n. 3, p. 1, doi. 10.1093/jncics/pkae030
    By:
    • Necchi, Andrea;
    • Ramlau, Rodryg;
    • González, Alejandro Falcón;
    • Chaudhry, Arvind;
    • Todenhöfer, Tilman;
    • Tahbaz, Rana;
    • Fontana, Elisa;
    • Giannatempo, Patrizia;
    • Deville, Jean-Laurent;
    • Pouessel, Damien;
    • Yoon, Shinkyo;
    • Powles, Thomas;
    • Bernat, Mathieu;
    • Häckl, Manuel;
    • Marszewska, Michalina;
    • McKernan, Phil;
    • Saulay, Mikael;
    • Scaleia, Federica;
    • Engelhardt, Marc;
    • Loriot, Yohann
    Publication type:
    Article
    3
    4

    Pemetrexed-Induced Pneumonitis: A Case Report.

    Published in:
    Clinical Lung Cancer, 2009, v. 10, n. 5, p. 364, doi. 10.3816/CLC.2009.n.050
    By:
    • Loriot, Yohann;
    • Ferte, Charles;
    • Gomez-Roca, Carlos;
    • Moldovan, Christian;
    • Bahleda, Ratislav;
    • Wislez, Marie;
    • Cadranel, Jacques;
    • Soria, Jean-Charles
    Publication type:
    Article
    5
    6

    Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 Study.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 1, p. N.PAG, doi. 10.1016/j.clgc.2024.102261
    By:
    • Powles, Thomas;
    • Csőszi, Tibor;
    • Loriot, Yohann;
    • Matsubara, Nobuaki;
    • Geczi, Lajos;
    • Cheng, Susanna Y-S;
    • Fradet, Yves;
    • Alva, Ajjai;
    • Oudard, Stéphane;
    • Vulsteke, Christof;
    • Morales-Barrera, Rafael;
    • Fléchon, Aude;
    • Gunduz, Seyda;
    • Liu, Chih-Chin;
    • Moreno, Blanca Homet;
    • Bavle, Abhishek;
    • Özgüroğlu, Mustafa
    Publication type:
    Article
    7

    Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 4, p. N.PAG, doi. 10.1016/j.clgc.2024.102091
    By:
    • Tateo, Valentina;
    • Cigliola, Antonio;
    • Mercinelli, Chiara;
    • Agarwal, Neeraj;
    • Grivas, Petros;
    • Kamat, Ashish M.;
    • Gibb, Ewan A.;
    • Moschini, Marco;
    • Brausi, Maurizio;
    • Dyrskjøt, Lars;
    • Loriot, Yohann;
    • Gupta, Shilpa;
    • Colecchia, Maurizio;
    • Spiess, Philippe E.;
    • Ross, Jeffrey S.;
    • Necchi, Andrea
    Publication type:
    Article
    8

    Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

    Published in:
    Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. 554, doi. 10.1016/j.clgc.2021.08.005
    By:
    • Culine, Stéphane;
    • Harter, Valentin;
    • Gravis, Gwenaelle;
    • Fléchon, Aude;
    • Chevreau, Christine;
    • Mahammedi, Hakim;
    • Laguerre, Brigitte;
    • Guillot, Aline;
    • Joly, Florence;
    • Abadie-Lacourtoisie, Sophie;
    • Geoffrois, Lionnel;
    • Di Fiore, Frédéric;
    • Roubaud, Guilhem;
    • Barthélémy, Philippe;
    • Voog, Eric;
    • Emambux, Sheik;
    • Serrate, Camille;
    • Saldana, Carolina;
    • Nguyen-Tan-Hon, Thierry;
    • Loriot, Yohann
    Publication type:
    Article
    9

    Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.

    Published in:
    Arthritis & Rheumatology, 2019, v. 71, n. 12, p. 2100, doi. 10.1002/art.41068
    By:
    • Tison, Alice;
    • Quéré, Gilles;
    • Misery, Laurent;
    • Funck‐Brentano, Elisa;
    • Danlos, François‐Xavier;
    • Routier, Emilie;
    • Robert, Caroline;
    • Loriot, Yohann;
    • Lambotte, Olivier;
    • Bonniaud, Bertille;
    • Scalbert, Camille;
    • Maanaoui, Sarah;
    • Lesimple, Thierry;
    • Martinez, Stéphanie;
    • Marcq, Marie;
    • Chouaid, Christos;
    • Dubos, Catherine;
    • Brunet‐Possenti, Florence;
    • Stavris, Chloé;
    • Chiche, Laurent
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).

    Published in:
    International Journal of Cancer, 2018, v. 143, n. 10, p. 2584, doi. 10.1002/ijc.31752
    By:
    • Andree, Kiki C.;
    • Mentink, Anouk;
    • Zeune, Leonie L.;
    • Terstappen, Leon W.M.M.;
    • Stoecklein, Nikolas H.;
    • Neves, Rui P.;
    • Driemel, Christiane;
    • Lampignano, Rita;
    • Yang, Liwen;
    • Neubauer, Hans;
    • Fehm, Tanja;
    • Fischer, Johannes C.;
    • Rossi, Elisabetta;
    • Manicone, Mariangela;
    • Basso, Umberto;
    • Marson, Piero;
    • Zamarchi, Rita;
    • Loriot, Yohann;
    • Lapierre, Valerie;
    • Faugeroux, Vincent
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15426-2
    By:
    • Faugeroux, Vincent;
    • Pailler, Emma;
    • Oulhen, Marianne;
    • Deas, Olivier;
    • Brulle-Soumare, Laura;
    • Hervieu, Céline;
    • Marty, Virginie;
    • Alexandrova, Kamelia;
    • Andree, Kiki C.;
    • Stoecklein, Nikolas H.;
    • Tramalloni, Dominique;
    • Cairo, Stefano;
    • NgoCamus, Maud;
    • Nicotra, Claudio;
    • Terstappen, Leon W. M. M.;
    • Manaresi, Nicolo;
    • Lapierre, Valérie;
    • Fizazi, Karim;
    • Scoazec, Jean-Yves;
    • Loriot, Yohann
    Publication type:
    Article
    25

    Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

    Published in:
    Cancers, 2024, v. 16, n. 8, p. 1465, doi. 10.3390/cancers16081465
    By:
    • Mokbel, Sara;
    • Baciarello, Giuilia;
    • Lavaud, Pernelle;
    • Omlin, Aurelius;
    • Calabrò, Fabio;
    • Cathomas, Richard;
    • Aeppli, Stefanie;
    • Parent, Pauline;
    • Giannatempo, Patrizia;
    • Koster, Kira-Lee;
    • Appel, Naara;
    • Gonnet, Philippe;
    • Angius, Gesuino;
    • Tsantoulis, Petros;
    • Arkenau, Hendrick-Tobias;
    • Cattrini, Carlo;
    • Messina, Carlo;
    • Zeghondy, Jean;
    • Morelli, Cristina;
    • Loriot, Yohann
    Publication type:
    Article
    26

    Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.

    Published in:
    Cancers, 2023, v. 15, n. 4, p. 1066, doi. 10.3390/cancers15041066
    By:
    • Parent, Pauline;
    • Auclin, Edouard;
    • Patrikidou, Anna;
    • Mezquita, Laura;
    • Martínez Chanzá, Nieves;
    • Dumont, Clément;
    • Rodriguez-Vida, Alejo;
    • Llacer, Casilda;
    • Lozano, Rebeca;
    • Ratta, Raffaele;
    • Merseburger, Axel S.;
    • Sternberg, Cora N.;
    • Baciarello, Giulia;
    • Colomba, Emeline;
    • Fuerea, Alina;
    • Besse, Benjamin;
    • Loriot, Yohann;
    • Lavaud, Pernelle
    Publication type:
    Article
    27

    Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee.

    Published in:
    Cancers, 2022, v. 14, n. 21, p. 5452, doi. 10.3390/cancers14215452
    By:
    • Masson-Lecomte, Alexandra;
    • Vaillant, Victoire;
    • Roumiguié, Mathieu;
    • Lévy, Stéphan;
    • Pradère, Benjamin;
    • Peyromaure, Michaël;
    • Duquesne, Igor;
    • De La Taille, Alexandre;
    • Lebâcle, Cédric;
    • Panis, Adrien;
    • Traxer, Olivier;
    • Leon, Priscilla;
    • Hulin, Maud;
    • Xylinas, Evanguelos;
    • Audenet, François;
    • Seisen, Thomas;
    • Loriot, Yohann;
    • Allory, Yves;
    • Rouprêt, Morgan;
    • Neuzillet, Yann
    Publication type:
    Article
    28
    29
    30
    31
    32

    Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

    Published in:
    Journal of Crohn's & Colitis, 2017, v. 11, n. 10, p. 1238, doi. 10.1093/ecco-jcc/jjx081
    By:
    • Coutzac, Clélia;
    • Adam, Julien;
    • Soularue, Emilie;
    • Collins, Michael;
    • Racine, Antoine;
    • Mussini, Charlotte;
    • Boselli, Lisa;
    • Kamsukom, Nyam;
    • Mateus, Christine;
    • Charrier, Mélinda;
    • Cassard, Lydie;
    • Planchard, David;
    • Ribrag, Vincent;
    • Fizazi, Karim;
    • Loriot, Yohann;
    • Lepage, Patricia;
    • Scoazec, Jean-Yves;
    • Robert, Caroline;
    • Carbonnel, Franck;
    • Chaput, Nathalie
    Publication type:
    Article
    33

    Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35601
    By:
    • O'Donnell, Peter H.;
    • Loriot, Yohann;
    • Csoszi, Tibor;
    • Matsubara, Nobuaki;
    • Shin, Sang Joon;
    • Park, Se Hoon;
    • Atduev, Vagif;
    • Gumus, Mahmut;
    • Karaca, Saziye Burcak;
    • Grivas, Petros;
    • de Wit, Ronald;
    • Castellano, Daniel E.;
    • Powles, Thomas;
    • Vuky, Jacqueline;
    • Zhao, Yujie;
    • O'Hara, Karen;
    • Okpara, Chinyere E.;
    • Franco, Sonia;
    • Homet Moreno, Blanca;
    • Żołnierek, Jakub
    Publication type:
    Article
    34

    Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 10, p. 1516, doi. 10.1007/s10147-024-02583-3
    By:
    • Matsubara, Nobuaki;
    • Miura, Yuji;
    • Nishiyama, Hiroyuki;
    • Taoka, Rikiya;
    • Kojima, Takahiro;
    • Shimizu, Nobuaki;
    • Hwang, Jason;
    • Ote, Tatsuya;
    • Oyama, Ryo;
    • Toyoizumi, Kiichiro;
    • Mukhopadhyay, Sutapa;
    • Triantos, Spyros;
    • Deprince, Kris;
    • Loriot, Yohann
    Publication type:
    Article
    35
    36
    37

    The genomic and transcriptomic landscape of metastastic urothelial cancer.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52915-0
    By:
    • Loriot, Yohann;
    • Kamal, Maud;
    • Syx, Laurene;
    • Nicolle, Remy;
    • Dupain, Celia;
    • Mensourri, Naoual;
    • Duquesne, Igor;
    • Lavaud, Pernelle;
    • Nicotra, Claudio;
    • Ngocamus, Maud;
    • Lacroix, Ludovic;
    • Tselikas, Lambros;
    • Crehange, Gilles;
    • Friboulet, Luc;
    • Castel-Ajgal, Zahra;
    • Neuzillet, Yann;
    • Borcoman, Edith;
    • Beuzeboc, Philippe;
    • Marret, Grégoire;
    • Gutman, Tom
    Publication type:
    Article
    38
    39

    Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review.

    Published in:
    Current Oncology Reports, 2024, v. 26, n. 10, p. 1236, doi. 10.1007/s11912-024-01576-9
    By:
    • Mathiot, Laurent;
    • Baldini, Capucine;
    • Letissier, Octave;
    • Hollebecque, Antoine;
    • Bahleda, Rastislav;
    • Gazzah, Anas;
    • Smolenschi, Cristina;
    • Sakkal, Madona;
    • Danlos, François-Xavier;
    • Henon, Clémence;
    • Beshiri, Kristi;
    • Goldschmidt, Vincent;
    • Parisi, Claudia;
    • Patrikidou, Anna;
    • Michot, Jean-Marie;
    • Marabelle, Aurélien;
    • Postel-Vinay, Sophie;
    • Bernard-Tessier, Alice;
    • Loriot, Yohann;
    • Ponce, Santiago
    Publication type:
    Article
    40

    Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.

    Published in:
    NPJ Precision Oncology, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41698-020-00130-7
    By:
    • Recondo, Gonzalo;
    • Mahjoubi, Linda;
    • Maillard, Aline;
    • Loriot, Yohann;
    • Bigot, Ludovic;
    • Facchinetti, Francesco;
    • Bahleda, Rastislav;
    • Gazzah, Anas;
    • Hollebecque, Antoine;
    • Mezquita, Laura;
    • Planchard, David;
    • Naltet, Charles;
    • Lavaud, Pernelle;
    • Lacroix, Ludovic;
    • Richon, Catherine;
    • Lovergne, Aurelie Abou;
    • De Baere, Thierry;
    • Tselikas, Lambros;
    • Deas, Olivier;
    • Nicotra, Claudio
    Publication type:
    Article
    41

    PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.

    Published in:
    Drugs, 2022, v. 82, n. 7, p. 719, doi. 10.1007/s40265-022-01703-5
    By:
    • Flippot, Ronan;
    • Patrikidou, Anna;
    • Aldea, Mihaela;
    • Colomba, Emeline;
    • Lavaud, Pernelle;
    • Albigès, Laurence;
    • Naoun, Natacha;
    • Blanchard, Pierre;
    • Terlizzi, Mario;
    • Garcia, Camilo;
    • Bernard-Tessier, Alice;
    • Fuerea, Alina;
    • Di Palma, Mario;
    • Escudier, Bernard;
    • Loriot, Yohann;
    • Baciarello, Giulia;
    • Fizazi, Karim
    Publication type:
    Article
    42
    43

    Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test.

    Published in:
    Cells (2073-4409), 2022, v. 11, n. 12, p. 1901, doi. 10.3390/cells11121901
    By:
    • Vasseur, Damien;
    • Sassi, Hela;
    • Bayle, Arnaud;
    • Tagliamento, Marco;
    • Besse, Benjamin;
    • Marzac, Christophe;
    • Arbab, Ahmadreza;
    • Auger, Nathalie;
    • Cotteret, Sophie;
    • Aldea, Mihaela;
    • Blanc-Durand, Félix;
    • Géraud, Arthur;
    • Gazzah, Anas;
    • Loriot, Yohann;
    • Hollebecque, Antoine;
    • Martín-Romano, Patricia;
    • Ngo-Camus, Maud;
    • Nicotra, Claudio;
    • Ponce, Santiago;
    • Sakkal, Madona
    Publication type:
    Article
    44

    Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.

    Published in:
    Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01878-9
    By:
    • Bayle, Arnaud;
    • Belcaid, Laila;
    • Palmieri, Lola-Jade;
    • Teysonneau, Diego;
    • Cousin, Sophie;
    • Spalato-Ceruso, Mariella;
    • Aldea, Mihaela;
    • Vasseur, Damien;
    • Alame, Melissa;
    • Blouin, Laura;
    • Soubeyran, Isabelle;
    • Nicotra, Claudio;
    • Ngocamus, Maud;
    • Hollebecque, Antoine;
    • Loriot, Yohann;
    • Besse, Benjamin;
    • Lacroix, Ludovic;
    • Rouleau, Etienne;
    • Barlesi, Fabrice;
    • Andre, Fabrice
    Publication type:
    Article
    45

    Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study.

    Published in:
    Investigational New Drugs, 2014, v. 32, n. 5, p. 995, doi. 10.1007/s10637-014-0101-x
    By:
    • Loriot, Yohann;
    • Fizazi, Karim;
    • Jones, Robert;
    • Brande, Jan;
    • Molife, Rhoda;
    • Omlin, Aurelius;
    • James, Nicholas;
    • Baskin-Bey, Edwina;
    • Heeringa, Marten;
    • Baron, Benoit;
    • Holtkamp, Gertjan;
    • Ouatas, Taoufik;
    • Bono, Johann
    Publication type:
    Article
    46

    Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.

    Published in:
    Investigational New Drugs, 2014, v. 32, n. 2, p. 312, doi. 10.1007/s10637-013-9993-0
    By:
    • Lazar, Vladimir;
    • Lassau, Nathalie;
    • Meurice, Guillaume;
    • Loriot, Yohann;
    • Peña, Carol;
    • Massard, Christophe;
    • Robert, Caroline;
    • Robert, Thomas;
    • Berre, Marie-Aude;
    • Baere, Thierry;
    • Dessen, Philippe;
    • Soria, Jean-Charles;
    • Armand, Jean-Pierre
    Publication type:
    Article
    47
    48
    49
    50